Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Botox
Active Ingredient:	Botulinum toxin type A 50U
Dosage Form:	Powder for injection
New Zealand Sponsor:	AbbVie Limited
Manufacturer:	Allergan Pharmaceuticals Ireland, Westport, Ireland

*Product:*	Botox
Active Ingredient:	Botulinum toxin type A 100U
Dosage Form:	Powder for injection
New Zealand Sponsor:	AbbVie Limited
Manufacturer:	Allergan Pharmaceuticals Ireland, Westport, Ireland

*Product:*	Botox
Active Ingredient:	Botulinum toxin type A 200U
Dosage Form:	Powder for injection
New Zealand Sponsor:	AbbVie Limited
Manufacturer:	Allergan Pharmaceuticals Ireland, Westport, Ireland

*Product:*	OncoTICE
Active Ingredient:	Bacillus Calmette-Guerin 500MCFU
Dosage Form:	Powder for injection
New Zealand Sponsor:	Merck Sharp & Dohme (New Zealand) Limited
Manufacturer:	Merck Teknika LLC, North Carolina, United States of America

Dated this 16th day of July 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule